Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2005 How Good Is Good Enough? Commentary 1 G. Caleb Alexander, MD, MS Virtual Mentor. 2005;7(7):464-466. doi: 10.1001/virtualmentor.2005.7.7.ccas2-0507. Case and Commentary Jul 2005 How Good Is Good Enough? Commentary 2 Robert C. Bowman, MD Virtual Mentor. 2005;7(7):466-468. doi: 10.1001/virtualmentor.2005.7.7.ccas2-0507. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Case and Commentary Jul 2005 How Good Is Good Enough? Commentary 1 G. Caleb Alexander, MD, MS Virtual Mentor. 2005;7(7):464-466. doi: 10.1001/virtualmentor.2005.7.7.ccas2-0507.
Case and Commentary Jul 2005 How Good Is Good Enough? Commentary 2 Robert C. Bowman, MD Virtual Mentor. 2005;7(7):466-468. doi: 10.1001/virtualmentor.2005.7.7.ccas2-0507.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.